XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment upon adoption of ASU No. 2016-13
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Net Income
Cumulative-effect adjustment upon adoption of ASU No. 2016-13
Cumulative Distributions
Beginning balance (in shares) at Dec. 31, 2021     14,597,000        
Beginning balance at Dec. 31, 2021 $ 257,694   $ 15 $ 237,624 $ 24,650   $ (4,595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants 82     82      
Net income 11,126       11,126    
Distributions (3,649)           (3,649)
Ending balance (in shares) at Mar. 31, 2022     14,597,000        
Ending balance at Mar. 31, 2022 $ 265,253   $ 15 237,706 35,776   (8,244)
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]            
Beginning balance (in shares) at Dec. 31, 2021     14,597,000        
Beginning balance at Dec. 31, 2021 $ 257,694   $ 15 237,624 24,650   (4,595)
Ending balance (in shares) at Dec. 31, 2022 14,709,165   14,709,000        
Ending balance at Dec. 31, 2022 $ 271,579 $ (6,595) $ 15 238,505 52,290 $ (6,595) (19,231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share grants $ 121     121      
Share repurchases (in shares) (1,503)   (1,000)        
Share repurchases $ (13)     (13)      
Share forfeitures (in shares)     (1,000)        
Share forfeitures (1)     (1)      
Net income 7,803       7,803    
Distributions $ (5,147)           (5,147)
Ending balance (in shares) at Mar. 31, 2023 14,706,862   14,707,000        
Ending balance at Mar. 31, 2023 $ 267,747   $ 15 $ 238,612 $ 53,498   $ (24,378)